Evidence map›Paper›PMID 39714856›Full record

ArticleJAMA dermatology2025

Immune Checkpoint Inhibitor-Induced Vitiligo-Like Depigmentation.

Michela Starace, Stephano Cedirian, Luca Rapparini, Alessandro Pileri, Cristina Carrera, Priscila Giavedoni, M Teresa Alonso de Leon, Lukas Kraehenbuehl, Yannick S Elshot, Zoe Apalla and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Michela StaraceDermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Stephano CedirianDermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Luca RappariniDermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Alessandro PileriDermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Cristina CarreraDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Priscila GiavedoniDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
M Teresa Alonso de LeonDepartment of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Lukas KraehenbuehlDepartment of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Yannick S ElshotDepartment of Dermatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
Zoe ApallaFirst Department of Dermatology, Aristotle University, Thessaloniki, Greece.
Chryssoula PapegeorgiouFirst Department of Dermatology, Aristotle University, Thessaloniki, Greece.
Vasiliki NikolaouDepartment of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
Tatjana RadevicDepartment of Dermatology and Venereology, Medical Faculty of the Military Medical Academy, University of Defense, Belgrade, Serbia.
Zsuzsanna LengyelDepartment of Dermatology, Venerology and Oncodermatology, University of Pécs, Pécs, Hungary.
Pietro SollenaDermatology Unit, Department of Surgical and Medical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Ketty PerisDermatology Unit, Department of Surgical and Medical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Ernesto RossiDivision of Medical Oncology, Fondazione Policlinico "A. Gemelli" Istituto di Ricerca e Cura a Carattere Scientifico, Rome, Italy.
Davide FattoreSection of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Dimitra KoumakiDepartment of Dermatology, University Hospital of Heraklion, Heraklion, Greece.
Aram BoadaDermatology Department, Hospital Germans Trias I Pujol de Badalona, Badalona, Spain.
Ana-Maria ForseaCarol Davila University of Medicine and Pharmacy Bucharest, Department of Oncologic Dermatology, Elias University Hospital Bucharest, Bucharest, Romania.
Sonia SeguraDepartment of Dermatology, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
Azael Freites-MartinezDepartment of Dermatology, Hospital Ruber de Juan Bravo, Universidad Europea, Madrid, Spain.
Julia RigantiDermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Emily Avitan-HershDepartment of Dermatology, Rambam Health Care Campus.
Nada SaffuriDepartment of Dermatology, Rambam Health Care Campus.
Lucie PeuvrelInstitut de Cancérologie de l'Ouest, Saint-Herblain, France.
Frédéric DezoteuxCHU Lille, Service de Dermatologie, Université de Lille, INSERM U1286, Lille Inflammation Translational Research Institute, Lille, France.
Bianca Maria PiracciniDermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Vincent SibaudOncodermatology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39714856
PMCPMC11840635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.